Arch Biopartners Inc.
Arch Biopartners Inc. (ARCH.V) Revenue
Annual & quarterly revenue history · segment & region breakdown
ARCH.V · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsArch Biopartners Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-09-30 | $0.00B | -$0.00B | -100.00% |
| 2024-09-30 | $0.00B | +$0.00B | +6.96% |
| 2023-09-30 | $0.00B | +$0.00B | +105.66% |
| 2022-09-30 | $0.00B | -$0.00B | -75.18% |
| 2021-09-30 | $0.00B | +$0.00B | +5625.78% |
| 2020-09-30 | $0.00B | -$0.00B | -27.69% |
| 2019-09-30 | $0.00B | +$0.00B | — |
| 2018-09-30 | $0.00B | +$0.00B | — |
| 2017-09-30 | $0.00B | +$0.00B | — |
| 2016-09-30 | $0.00B | -$0.00B | -100.00% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Arch Biopartners Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Arch Biopartners Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Arch Biopartners Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ARCH.V revenue · 4 questionsARCH.V's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Arch Biopartners Inc. SEC filings · GAAP · Arch Biopartners Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026